Official Title
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in COVID-19 Infection
Brief Summary

This study seeks to determine whether the virus which causes COVID-19, SARS-CoV-2, is shed in the stools of patients who are infected.

Detailed Description

In this study the stool of patients who are being treated for COVID-19 will be tested during
treatment and then again following treatment to determine if the virus is shed in the stool
during infection, afterwards, or both.

Recruiting
Gut Microbiome
Gastrointestinal Microbiome
COVID
COVID-19
Corona Virus Infection
Coronavirus
Coronaviridae Infections
Coronavirus 19
Coronavirus-19
COVID 19

Other: There is no intervention in this study

There is no intervention in this study

Eligibility Criteria

Inclusion Criteria:

1. Signed informed consent, demonstrating that the patient understands the procedures
required for the study and the purpose of the study

2. Male or female of 18 years of age or older

3. Diagnosis of COVID-19 infection by RT- PCR within 1 week of Screening

Exclusion Criteria:

1. Refusal to sign informed consent form

2. History of bariatric surgery, total colectomy with ileorectal anastomosis or
proctocolectomy.

3. Postoperative stoma, ostomy, or ileoanal pouch

4. Treatment with total parenteral nutrition

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
United States
Locations

ProgenaBiome
Ventura, California, United States

Investigator: Sabine Hazan, MD
Contact: 805-339-0549
drsabinehazan@progenabiome.com

Investigator: Sabine Hazan, MD

Contacts

Sabine Hazan, MD
805-339-0549
drsabinehazan@progenabiome.com

Jordan Daniels, MS
217-494-6692
jordan@progenabiome.com

Sabine Hazan, MD, Principal Investigator
ProgenaBiome

NCT Number
Keywords
Microbiome
Coronavirus
Corona Virus
19
Covid
Covid-19
MeSH Terms
Infections
Communicable Diseases
COVID-19
Coronavirus Infections
Coronaviridae Infections